Cargando…

P268 Laryngeal Mucormycosis: does mucor take the voice away?

POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM:   OBJECTIVE: This case aims to highlight a unique presentation of Mucormycosis. METHODS AND RESULTS: A 57-year-old retired office supervisor, presented to the ENT department with complaints of hoarseness of voice ending with almost complete d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rege, Sujata, Soman, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510005/
http://dx.doi.org/10.1093/mmy/myac072.P268
_version_ 1784797355585830912
author Rege, Sujata
Soman, Rajeev
author_facet Rege, Sujata
Soman, Rajeev
author_sort Rege, Sujata
collection PubMed
description POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM:   OBJECTIVE: This case aims to highlight a unique presentation of Mucormycosis. METHODS AND RESULTS: A 57-year-old retired office supervisor, presented to the ENT department with complaints of hoarseness of voice ending with almost complete dysphonia over 6 months. There were no complaints of stridor, dyspnea or dysphagia. He had no history of prior surgery or tracheal intubation. On examination, a lesion over his right vocal cord was noted (Fig. 1) and underwent surgical excision of the lesion. HPE of the lesion (Fig. 2) showed hyperplastic stratified squamous epithelium which was partly ulcerated and covered by thick bands of necro-inflammatory material. Within the necrotic material were seen broad aseptate fungal hyphae. Beneath the necrotic material was inflamed granulation tissue with fibrosis. No tissue or vascular invasion was noted as per the report, however there was a recurrence of the lesion after 15 days. ID team opinion was sought in view of need for antifungals. Owing to financial constraints, CT chest could not be done, but his chest X-ray was normal. His HbA1c was 7.5%, which was suggestive of newly detected diabetes mellitus (DM). In this case, even though no angioinvasion or tissue invasion was reported, the presence of hyphae in the area of necrosis, the presence of inflammatory local tissue reaction, coupled with newly detected DM, prompted the ID team to advise treatment with amphotericin B followed by suspension posaconazole (GR was not available at the that time). The patient was not willing for treatment at the time. However, local recurrence of the lesion occurred 2 weeks later. Surgical resection along with posaconazole, TDM and close follow-up was advised. However, the patient was lost to follow-up, possibly due to loss of confidence in us? CONCLUSION: The importance of sending every surgically excised tissue for histopathology and culture has been highlighted by this case. Early ID opinion and AF therapy could have averted recurrence and loss of patient confidence. Chronic Granulomatous form of mucormycosis though rare, needs timely diagnosis and treatment in the form of surgical resection as well as systemic antifungal therapy.
format Online
Article
Text
id pubmed-9510005
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95100052022-09-26 P268 Laryngeal Mucormycosis: does mucor take the voice away? Rege, Sujata Soman, Rajeev Med Mycol Oral Presentations POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM:   OBJECTIVE: This case aims to highlight a unique presentation of Mucormycosis. METHODS AND RESULTS: A 57-year-old retired office supervisor, presented to the ENT department with complaints of hoarseness of voice ending with almost complete dysphonia over 6 months. There were no complaints of stridor, dyspnea or dysphagia. He had no history of prior surgery or tracheal intubation. On examination, a lesion over his right vocal cord was noted (Fig. 1) and underwent surgical excision of the lesion. HPE of the lesion (Fig. 2) showed hyperplastic stratified squamous epithelium which was partly ulcerated and covered by thick bands of necro-inflammatory material. Within the necrotic material were seen broad aseptate fungal hyphae. Beneath the necrotic material was inflamed granulation tissue with fibrosis. No tissue or vascular invasion was noted as per the report, however there was a recurrence of the lesion after 15 days. ID team opinion was sought in view of need for antifungals. Owing to financial constraints, CT chest could not be done, but his chest X-ray was normal. His HbA1c was 7.5%, which was suggestive of newly detected diabetes mellitus (DM). In this case, even though no angioinvasion or tissue invasion was reported, the presence of hyphae in the area of necrosis, the presence of inflammatory local tissue reaction, coupled with newly detected DM, prompted the ID team to advise treatment with amphotericin B followed by suspension posaconazole (GR was not available at the that time). The patient was not willing for treatment at the time. However, local recurrence of the lesion occurred 2 weeks later. Surgical resection along with posaconazole, TDM and close follow-up was advised. However, the patient was lost to follow-up, possibly due to loss of confidence in us? CONCLUSION: The importance of sending every surgically excised tissue for histopathology and culture has been highlighted by this case. Early ID opinion and AF therapy could have averted recurrence and loss of patient confidence. Chronic Granulomatous form of mucormycosis though rare, needs timely diagnosis and treatment in the form of surgical resection as well as systemic antifungal therapy. Oxford University Press 2022-09-20 /pmc/articles/PMC9510005/ http://dx.doi.org/10.1093/mmy/myac072.P268 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Presentations
Rege, Sujata
Soman, Rajeev
P268 Laryngeal Mucormycosis: does mucor take the voice away?
title P268 Laryngeal Mucormycosis: does mucor take the voice away?
title_full P268 Laryngeal Mucormycosis: does mucor take the voice away?
title_fullStr P268 Laryngeal Mucormycosis: does mucor take the voice away?
title_full_unstemmed P268 Laryngeal Mucormycosis: does mucor take the voice away?
title_short P268 Laryngeal Mucormycosis: does mucor take the voice away?
title_sort p268 laryngeal mucormycosis: does mucor take the voice away?
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510005/
http://dx.doi.org/10.1093/mmy/myac072.P268
work_keys_str_mv AT regesujata p268laryngealmucormycosisdoesmucortakethevoiceaway
AT somanrajeev p268laryngealmucormycosisdoesmucortakethevoiceaway